Company Information & Drug Savings for Chelsea Therapeutics Medications
Chelsea Therapeutics, acquired by Lundbeck, was a pharmaceutical company focused on autonomic dysfunction treatments. The company developed Northera (droxidopa) for neurogenic orthostatic hypotension (NOH), a debilitating blood pressure drop upon standing associated with Parkinson’s disease, multiple system atrophy, and autonomic failure. Lundbeck continues developing treatments for neurological disorders.
How to Contact Chelsea Therapeutics
Phone
1-704-341-1500Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
